ARTICLE | Clinical News
Metreleptin regulatory update
April 9, 2012 7:00 AM UTC
Amylin completed submission of a rolling BLA to FDA for metreleptin to treat diabetes and/or hypertriglyceridemia in patients with rare forms of lipodystrophy. The company requested Priority Review fo...